Basilea Pharmaceutica AG | Cash Flow
Fiscal year is January-December. All values CHF Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
33,019.90
41,545.50
61,603.00
51,287.00
19,360.00
31,352
Depreciation, Depletion & Amortization
2,715.50
2,590.80
2,527.00
2,319.00
1,991.00
1,852
Other Funds
3,711.40
5,914.40
9,280.00
8,796.00
5,374.00
7,009
Funds from Operations
26,593.10
33,040.30
49,796.00
40,172.00
11,995.00
22,491
Changes in Working Capital
32,876.80
38,421.20
17,984.00
34,831.00
31,009.00
56,719
Net Operating Cash Flow
59,469.80
71,461.50
67,780.00
75,003.00
19,014.00
79,210
Capital Expenditures
1,206.30
1,312.30
1,312.00
431.00
945.00
Sale of Fixed Assets & Businesses
16.90
6.20
9.00
7.00
5.00
Purchase/Sale of Investments
35,000.00
85,000.00
18,400.00
1,635.00
60,000.00
Net Investing Cash Flow
36,189.40
83,693.90
17,097.00
1,211.00
60,940.00
Issuance/Reduction of Debt, Net
-
-
194,687.00
-
-
Net Financing Cash Flow
9,454.80
24,860.20
208,063.00
411.00
2,631.00
Net Change in Cash
105,057.80
37,227.80
156,939.00
74,034.00
38,306.00
Free Cash Flow
60,572.50
72,709.00
68,789.00
75,397.00
18,303.00
Change in Capital Stock
9,454.80
24,860.20
13,376.00
411.00
2,631.00
Exchange Rate Effect
56.20
135.20
441.00
653.00
989.00
About Basilea Pharmaceutica
View Profile
